Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Easily worth $1.00, I'll take $0.10+..FDA APPROVED PRODUCTS, MEDICAL EQUIPMENT.
No Debt/Convertibles...INSIDERS hold 80-90% of OS!!
I see why the CEO Purchased $765,000 in Shares.
Amazing.....Pro Health Inc., a Tennessee company organized in 2016. It entered into a Sales Agreement with Provision Healthcare , LLC, a Tennessee limited liability company, in the selling of ProNova Equipment, which is a Proton Treatment device used in the treatment of cancer. Other than the sale of equipment, Pro Health will also be providing Total Solution Services related with the use of the Equipment.
FDA APPROVED CARDIO VASCULAR DETECTION >> Sales Agreement between Mike Wang and Dr. William Fang for the marketing and sales of Dr. Fang’s early detection system of Cardio Vascular diseases. The device provides unique 3D imaging for the Cardio Vascular conditions for patients and has already won approval of US FDA. It has very positive significance in helping preventing heart attacks, which are the number one killer in the US as well as in the world.
This thing gets any bid support and it flies! Soooo thiiin
The Company under the new management will focus its business in the health related industry. The Company’s Chairman and president, Mike Wang, is the owner of several health related businesses below with which The Company is evaluating the possibilities of forming several joint ventures. The Company might effectuate the joint ventures using stocks.
1.
Health & Beauty Group Inc. It is a California company in the business of R &D and sale of vitamins and nutritional supplements. It owns more than 20 formulas and engages contract manufacturers to make these products. The company has built up solid sales records both in the US as well as in China.
2.
Pro Health Inc., a Tennessee company organized in 2016. It entered into a Sales Agreement with Provision Healthcare , LLC, a Tennessee limited liability company, in the selling of ProNova Equipment, which is a Proton Treatment device used in the treatment of cancer. Other than the sale of equipment, Pro Health will also be providing Total Solution Services related with the use of the Equipment.
3.
Sales Agreement between Mike Wang and Dr. William Fang for the marketing and sales of Dr. Fang’s early detection system of Cardio Vascular diseases. The device provides unique 3D imaging for the Cardio Vascular conditions for patients and has already won approval of US FDA. It has very positive significance in helping preventing heart attacks, which are the number one killer in the US as well as in the world.
The Company is also planning to conduct acquisition. Mike Wang has approached several health related companies in China and met the management of potential acquisition targets. Rapid economic advances in China in the last thirty years have greatly improved the living standards in China. This in turn brings demand in healthcare products and services. Company feels strongly that despite the challenges of cross border business, we might be able to acquire some good growth companies and bring good values to our stockholders.
.0089*.0091 incredibly thin.
Thats a lot for sure.Thks for the info
The AS/OS are crazy but the CEO holds over 80%, Float is approximately 10-20m..
Looks good cheeky...This must really have a low ss!
Huge New Company/Website, Hundreds of Products >>> http://www.hbherb.com/
CEO Stock Purchase Agreement, the Company agreed to purchase 51% of common shares of the Seller, for an aggregate purchase price of $765,000, which consisting of 63,750,000 outstanding shares of the Company’s common stock at $0.012 per share.
NEW ACCOUNTANT/AUDIT JUNE 2018....Current Report Filing (8-k)Source: Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 2nd, 2018
America Great Health
(Exact name of registrant as specified in charter)
WYOMING
(State or other jurisdiction of incorporation)
0-27873
98-0178621
(Commission File Number)
(IRS Employer Identification No.)
1609 W Valley Blvd., #338,
Alhambra, CA 91803
28277
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: (626) 576-1299
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
? Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
? Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
? Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
? Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1934 (§240.12b-2 of this chapter)
Emerging growth company ? .
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ?
ITEM 4.01 Change in Registrant’s Certifying Accountant.
(a) Dismissal of Independent Registered Public Accounting Firm.
On January 28 2018, America Great Health (the “Company ” ) dismissed TAAD LLP ( “ TAAD ” ) as the Company’s independent registered public accounting firm.
The TAAD reports on the Company ’ s financial statements for the years ended June 30, 2017 and 2016 did not contain an adverse opinion or a disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles.
During the Company ’ s years ended June 30, 2017 and 2016 and through January 28 2018, (i) there were no disagreements with TAAD on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to TAAD ’ s satisfaction, would have caused TAAD to make reference to the subject matter of such disagreements in its reports on our consolidated financial statements for such years, and (ii) there were no reportable events as defined in Item 304(a)(1)(v) of Regulation S-K.
The Company has provided TAAD with a copy of the foregoing disclosures and requested that TAAD furnish a letter to the Securities and Exchange Commission stating whether or not it agrees with the above statements. A copy of such letter is filed as Exhibit 16.1 to this Current Report on Form 8-K.
(b) Engagement of New Independent Registered Public Accounting Firm.
On January 29, 2018, we engaged Sadler, Gibb & Associates, LLC ( “ Sadler Gibb ” ) as our independent registered public accounting firm to audit the Company ’ s consolidated financial statements as of June 30, 2018 and for the year then ended. Sadler Gibb will be performing reviews of the unaudited consolidated quarterly financial statements to be included in the Company ’ s quarterly reports on Form 10-Q for the year ended June 30, 2018 as well as going forward.
During each of the Company ’ s two most recent fiscal years and through the date of this report, (a) the Company has not engaged Sadler Gibb as either the principal accountant to audit the Company ’ s financial statements, or as an independent accountant to audit a significant subsidiary of the Company and on whom the principal accountant is expected to express reliance in its report; and (b) the Company or someone on its behalf did not consult Sadler Gibb with respect to (i) either: the application of accounting principles to a specified transaction, either completed or proposed; or the type of audit opinion that might be rendered on the Company ’ s financial statements, or (ii) any other matter that was either the subject of a disagreement or a reportable event as set forth in Items 304(a)(1)(iv) and (v) of Regulation S-K.
ITEM 9.01 Financial Statements and Exhibits.
Exhibit 16.1: Letter from TAAD LLP dated Feburary 2, 2018 to the Securities and Exchange Commission.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed by the undersigned hereunto duly authorized.
AMERICA GREAT HEALTH
Date: February 2 nd , 2018
By: /s/ Mike Wang
Name: Mike Wang
Title: President
REVERSE MERGER....Current Report Filing (8-k)Source: Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 04, 2018
America Great Health
(Exact name of registrant as specified in charter)
WYOMING
(State or other jurisdiction of incorporation)
0-27873
98-0178621
(Commission File Number)
(IRS Employer Identification No.)
1609 W Valley Blvd., #338,
Alhambra, CA 91803
28277
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: (626) 576-1299
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
? Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
? Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
? Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
? Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1934 (§240.12b-2 of this chapter)
Emerging growth company ? .
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ?
Item 1.01 Entry Into a Material Definitive Agreement.
On January 04, 2018, America Great Health (the “Company”) entered into a Stock Purchase Agreement (the “Stock Purchase Agreement”) with Health & Beauty Group, Inc. (the “Seller”), a California Corporation focus on manufacuring and distrubution of health supplements and costmetic beauty proucts. Pursuant to the Stock Purchase Agreement, the Company agreed to purchase 51% of common shares of the Seller, for an aggregate purchase price of $765,000, which consisting of 63,750,000 outstanding shares of the Company’s common stock at $0.012 per share.
The foregoing description of the Stock Purchase Agreement and its terms is qualified in its entirety by the full text of the agreement, which is filed as Exhibit 10.1 to, and incorporated by reference in, this report.
Item 9.01 Financial Statements and Exhibits.
The exhibit listed in the following Exhibit Index is filed as part of this report:
10.1 Stock Purchase Agreement dated January 04, 2018
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed by the undersigned hereunto duly authorized.
AMERICA GREAT HEALTH
Date: January 04, 2018
By: /s/ Mike Wang
Name: Mike Wang
Title: President
NEW COO....Current Report Filing (8-k)Source: Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 08, 2018
America Great Health
(Exact name of registrant as specified in charter)
WYOMING
(State or other jurisdiction of incorporation)
0-27873
98-0178621
(Commission File Number)
(IRS Employer Identification No.)
1609 W Valley Blvd., #338,
Alhambra, CA 91803
28277
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code: (626) 576-1299
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
? Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
? Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
? Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
? Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective January 02, 2018, the Board of Directors (the "Board") of America Great Health (the "Company") determined that it was in the best interest of the Company to hire a new Chief Operating Officer ("COO"). Accordingly, the Board approved the appointment of Andy Weichu Sheng as the Company's COO.
Mr. Sheng, age 62, has 30 years extensive experiences in business management and operation. Prior to current positions, Mr. Sheng served as President at Tradeshowusa.com since 2002; and Chief Executive Officer at Bizusa.us since 2013, Mr. Sheng served as President at Shoes Expert; during 1998 to 2002, Mr. Sheng served as President and Chief Executive Officer at Hemei Security; Mr. Sheng also served as President at SICO Group General Electric China Sole Distributor for three years since 1990.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed by the undersigned hereunto duly authorized.
AMERICA GREAT HEALTH
Date: January 08, 2018
By: /s/ Mike Wang
Name: Mike Wang
Title: President
NEW CEO.....Current Report Filing (8-k)Source: Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 27, 2017
America Great Health
(Exact name of registrant as specified in charter)
WYOMING
(State or other jurisdiction of incorporation)
0-27873 98-0178621(Commission File Number) (IRS Employer Identification No.)
1609 W Valley Blvd., #338,
Alhambra, CA 91803
28277
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code : (626) 576-1299
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
? Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
? Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
? Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
? Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective June 22, 2017, the Board of Directors (the "Board") of America Great Health (the "Company") determined that it was in the best interest of the Company to separate the role of President from the role of Chief Executive Officer ("CEO"). Accordingly, the Board approved the appointment of Herric Chan as the Company's CEO replacing Mike Q. Wang.
Mr. Chan, age 46, has 20 years extensive business experiences across investment banking, lending, real estate, sales & marketing, biotech, healthcare, and pharmaceutical industry. He currently serves as Director of Alliance Capital Group (Hong Kong) servicing the IPO, financial advisory, and asset management in Hong Kong and China markets; Associate Partner of Chimera Co. Ltd. (Thailand), a financial advisory and asset management firm servicing South East Asia and Taiwan markets; and CEO of Round Table Group, (California, CalBRE #02022089) a licensed brokerage firm in the US specializes in multinational M&A and commercial real estate markets..
Prior to current positions, Mr. Chan served as Managing Director at Evidia Biosciences, a clinical laboratory and pathology service provider consists of 3 labs servicing over 700 physicians in Southern California and Pennsylvania; Vice President at Amphastar Pharmaceutical, (NASDAQ:AMPH); and Director of International Society of Pharmaceutical Engineers (ISPE, 18,000 members in 90 countries worldwide) LA. Ch. Mr. Chan started his investment banking career back in 1990 as Operation Manager of Tse's Investment Ltd., the investment division of TSL, Ltd. (0417.HK), running stock and forex investment floor with 6 trading offices throughout HK.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed by the undersigned hereunto duly authorized.
AMERICA GREAT HEALTH
Date: June 26, 2017
By: /s/ Mike Wang
Name: Mike Wang
Title: President
CEO Holds 81% of OS, 16.1B of 20B.
4 Solid 8-Ks----MERGER/AUDIT/$765,000 in Commons by CEO, Plus NEW COO
CWNM: effective June 29,2017 Crown Marketing, CWNM, will change to America Great Health, AAGH:
http://otce.finra.org/DLSymbolNameChanges
NEW MANAGEMENT, NO IFO EXCEPT NAME. STOCK ACTIVE UP ON ANNOUNCEMENT, NOTHING SINCE.
Something may be up here. PPS edging up the past week or 2 on no volume. Now some little trades are making it go even higher.
Yes, it is amazing with that amount of shares, that this stock moves up and down fast on few shares traded.
Wow. They've really gone the extra mile. I wonder why the stock price is as high as it is. Ought to be at 0.000001.
But then it barely trades at all.
holly crapolla The number of shares outstanding of the registrant ’ s common stock as of August 9, 2016 was 20,056,021,800. Common stock, no par value, unlimited shares authorized;
Prior to new website, cwnm posted 1 million monthly income on sale of hoverboards and major revenue from sale of alfafa to china, no mention on new site, What happened?
Do you guys know what a PR is? Posting on iHub is not the way to get the word out to the public. It would be nice to see this right up in a PR with updated financial information. Business 101!
How about an update on the business
How about an ejuice set of 5 for $39.99?
Our new website is online: cwnmusa.com.
In a day or two our shopping cart will be ready. Smoking deals on the way. 55" big screen only $499 plus shipping.
10 pack halogen energy saving light bulbs $14.99.
Good luck with that. That is a real small bag of hope. Not much going on here for a while.
Looks like the turd woke up.
I'm grabbing shares down here and holding a bag of hope...
Someone give this stock some CPR! Hoping someone would pump this stock by now, so I can get out of this POS.
it needs to be up to line .10 at least omg LOL thats why its a turd LOL
Keep the faith. It's not going down. If u have held as long as me u are well over a year. That means you pay less in taxes
Keep the faith. It's not going down. If u have held as long as me u are well over a year. That means you pay less in taxes
looks like this turd has died.. LOL
Hope so. GO CWNM $$$$
I've held this stock for over a year. I'm spruced with the number of shares outstanding that this thing moves as easily off off 500 shares bought. I guess we wait for the next promotion. This thing once promoted will move easily above 10 cents
Can't figure it out. Some days a little action some days non.
where is this dead tree going? LOL
Anybody know when this money train is suppose to start?
19.98B
Ranks right up there. I am sure there is further information provided.
Doesn't take much to move it I'm in at an average of 3 cents. So once we get above that level I break even. Just can't get out with such low volume. I think a run here would easily go into the high teens
Same here and I got in at the wrong time. Who knows though maybe we will get another run.
Followers
|
53
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1937
|
Created
|
10/09/12
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |